Rizix-400 (Rifaximin 400mg Tablets), featured by Salvus Pharma, is proud to extend a rewarding business opportunity for its specialized gastroenterology range in Mohali. We invite pharma distributors and medical representatives in Panchkula to partner with us and cater to the growing need for advanced gastrointestinal treatments.
Rizix-400 is a leading product for conditions like Hepatic Encephalopathy and IBS-D, offering a unique opportunity for a profitable gastrointestinal range PCD franchise. Align your business with a product that has a clear market and clinical demand.
Why is a Rizix-400 Franchise in Mohali a Smart Choice?
- Niche Market Leadership: Rifaximin is a specialized molecule, and partnering with us for Rizix-400 allows you to become a key player in the gastroenterology segment in Panchkula.
- Monopoly-Based Distribution: We offer exclusive, monopoly-based distribution rights to our franchise partners, ensuring focused growth and higher returns.
- Unmatched Third-Party Manufacturing Standards: Our ISO and WHO-GMP certified facilities ensure that Rizix-400 meets the highest quality benchmarks, giving you a competitive advantage.
- Dedicated Partner Support: From marketing materials to logistical support, we provide everything you need to establish and grow your business successfully.
About Rizix-400 (Rifaximin 400mg)
Rizix-400 is a gut-selective antibiotic with minimal systemic absorption, making it a safe and effective treatment for various gastrointestinal disorders. Its primary indications include managing Hepatic Encephalopathy and providing relief from IBS with diarrhea.
Become Our Franchise Partner in Mohali!
Don't miss out on this exceptional opportunity. To learn more about our PCD Pharma franchise for the gastrointestinal range and our product Rizix-400, contact Salvus Pharma today.
